Puma Biotechnology
PBYI
PBYI
82 hedge funds and large institutions have $117M invested in Puma Biotechnology in 2023 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
19% more funds holding
Funds holding: 69 → 82 (+13)
2.62% more ownership
Funds ownership: 54.1% → 56.73% (+2.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
82
Holding in Top 10
1
Calls
$843K
Puts
$218K
Top Buyers
| 1 | +$4.73M | |
| 2 | +$1.79M | |
| 3 | +$731K | |
| 4 |
Jane Street
New York
|
+$596K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$582K |
Top Sellers
| 1 | -$6.19M | |
| 2 | -$1.25M | |
| 3 | -$253K | |
| 4 |
Renaissance Technologies
New York
|
-$231K |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$146K |